LMN.V vs. CORT
LMN.V (Lumine Group Inc) and CORT (Corcept Therapeutics Incorporated) are both stocks. LMN.V operates in Software - Application (Technology), while CORT operates in Biotechnology (Healthcare). Over the past 3 years, LMN.V returned 5.50%/yr vs 48.60%/yr for CORT. At a 0.10 correlation, their price movements are largely independent.
Performance
LMN.V vs. CORT - Performance Comparison
Loading charts...
Different Trading Currencies
LMN.V is traded in CAD, while CORT is traded in USD. To make them comparable, the CORT values have been converted to CAD using the latest available exchange rates.
Returns By Period
In the year-to-date period, LMN.V achieves a -16.54% return, which is significantly lower than CORT's 114.56% return.
LMN.V
- 1D
- -3.21%
- 1M
- 11.96%
- YTD
- -16.54%
- 6M
- -20.50%
- 1Y
- -50.93%
- 3Y*
- 5.50%
- 5Y*
- —
- 10Y*
- —
CORT
- 1D
- 1.26%
- 1M
- 43.18%
- YTD
- 114.56%
- 6M
- -10.93%
- 1Y
- 7.50%
- 3Y*
- 48.60%
- 5Y*
- 30.99%
- 10Y*
- 30.52%
LMN.V vs. CORT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | |
|---|---|---|---|---|
LMN.V Lumine Group Inc | -16.54% | -34.03% | 37.59% | 84.00% |
CORT Corcept Therapeutics Incorporated | 114.56% | -34.09% | 68.28% | 48.40% |
Correlation
The correlation between LMN.V and CORT is 0.06, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.06 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.09 |
Correlation (All Time) Calculated using the full available price history since Mar 24, 2023 | 0.10 |
Fundamentals
LMN.V:
CA$5.81B
CORT:
$7.66B
LMN.V:
CA$0.48
CORT:
$0.41
LMN.V:
47.57
CORT:
178.81
LMN.V:
10.35
CORT:
89.07
LMN.V:
7.03
CORT:
11.07
LMN.V:
7.00
CORT:
12.00
LMN.V:
CA$792.89M
CORT:
$769.10M
LMN.V:
CA$271.95M
CORT:
$755.64M
LMN.V:
CA$253.96M
CORT:
$3.66M
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
LMN.V vs. CORT — Risk / Return Rank
LMN.V
CORT
LMN.V vs. CORT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Lumine Group Inc (LMN.V) and Corcept Therapeutics Incorporated (CORT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| LMN.V | CORT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.06 | ||
| Sortino ratioReturn per unit of downside risk | -2.34 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.14 | -0.32 |
| Calmar ratioReturn relative to maximum drawdown | -0.77 | 0.12 | -0.88 |
| Martin ratioReturn relative to average drawdown | -1.13 | 0.21 | -1.34 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| LMN.V | CORT | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -0.96 | 0.10 | -1.06 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | — | 0.42 | — |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | — | 0.45 | — |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.22 | 0.11 | +0.11 |
Drawdowns
LMN.V vs. CORT - Drawdown Comparison
The maximum LMN.V drawdown since its inception was -66.64%, smaller than the maximum CORT drawdown of -95.15%. Use the drawdown chart below to compare losses from any high point for LMN.V and CORT.
Loading charts...
Drawdown Indicators
| LMN.V | CORT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -66.64% | -95.15% | +28.51% |
Max Drawdown (1Y)Largest decline over 1 year | -66.64% | -65.20% | -1.44% |
Max Drawdown (3Y)Largest decline over 3 years | -66.64% | -73.18% | +6.54% |
Max Drawdown (5Y)Largest decline over 5 years | — | -73.18% | — |
Max Drawdown (10Y)Largest decline over 10 years | — | -73.18% | — |
Current DrawdownCurrent decline from peak | -58.26% | -37.44% | -20.82% |
Average DrawdownAverage peak-to-trough decline | -17.68% | -55.38% | +37.70% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 45.06% | 35.77% | +9.29% |
Volatility
LMN.V vs. CORT - Volatility Comparison
The current volatility for Lumine Group Inc (LMN.V) is 14.32%, while Corcept Therapeutics Incorporated (CORT) has a volatility of 16.30%. This indicates that LMN.V experiences smaller price fluctuations and is considered to be less risky than CORT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| LMN.V | CORT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 14.32% | 16.30% | -1.98% |
Volatility (6M)Calculated over the trailing 6-month period | 38.82% | 85.03% | -46.21% |
Volatility (1Y)Calculated over the trailing 1-year period | 53.25% | 76.83% | -23.58% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 45.05% | 74.88% | -29.83% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 45.05% | 67.72% | -22.67% |
Dividends
LMN.V vs. CORT - Dividend Comparison
Neither LMN.V nor CORT has paid dividends to shareholders.
Financials
LMN.V vs. CORT - Financials Comparison
This section allows you to compare key financial metrics between Lumine Group Inc and Corcept Therapeutics Incorporated. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
LMN.V vs. CORT - Profitability Comparison
LMN.V - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Lumine Group Inc reported a gross profit of 43.76M and revenue of 204.93M. Therefore, the gross margin over that period was 21.4%.
CORT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a gross profit of 162.02M and revenue of 164.90M. Therefore, the gross margin over that period was 98.3%.
LMN.V - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Lumine Group Inc reported an operating income of 28.74M and revenue of 204.93M, resulting in an operating margin of 14.0%.
CORT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported an operating income of -49.60M and revenue of 164.90M, resulting in an operating margin of -30.1%.
LMN.V - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Lumine Group Inc reported a net income of 18.70M and revenue of 204.93M, resulting in a net margin of 9.1%.
CORT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Corcept Therapeutics Incorporated reported a net income of -31.20M and revenue of 164.90M, resulting in a net margin of -18.9%.
Frequently Asked Questions
LMN.V and CORT have a correlation of 0.06, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
Find the right allocation for LMN.V and CORT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer